At the time of diagnosis the tumor had molecular features consisting of isocitrate dehydrogenase 1 (IDH-1) wild type, epidermal growth factor receptor (EGFR) amplified, and O6-methylguanin-DNA-methyltransferase (MGMT) unmethylated. The gene discussed is EGFR; the disease is neoplasm.